Cargando…
Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study
In a previous study in end-stage renal disease (ESRD) hemodialysis patients, a single dose of Staphylococcus aureus type 5 and 8 capsular polysaccharides (T5/T8) conjugated to nontoxic recombinant Pseudomonas aeruginosa exotoxin A investigational vaccine showed no efficacy against S. aureus bacterem...
Autores principales: | Fattom, Ali, Matalon, Albert, Buerkert, John, Taylor, Kimberly, Damaso, Silvia, Boutriau, Dominique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514248/ https://www.ncbi.nlm.nih.gov/pubmed/25483694 http://dx.doi.org/10.4161/hv.34414 |
Ejemplares similares
-
Safety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03(B) adjuvant: Results of a randomized phase I trial
por: Levy, Jack, et al.
Publicado: (2015) -
Immunogenicity of a Bivalent Adjuvanted Glycoconjugate Vaccine against Salmonella Typhimurium and Salmonella Enteritidis
por: Fiorino, Fabio, et al.
Publicado: (2017) -
Role and plasticity of Th1 and Th17 responses in immunity to Staphylococcus aureus
por: Ferraro, Alessandra, et al.
Publicado: (2019) -
Simulating Immune Interference on the Effect of a Bivalent Glycoconjugate Vaccine against Haemophilus influenzae Serotypes “a” and “b”
por: Konini, Angjelina, et al.
Publicado: (2016) -
Staphylococcus aureus nasal carriage in hemodialysis centers of Fez, Morocco
por: Diawara, Idrissa, et al.
Publicado: (2014)